Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).

@article{Lee1994ReductionIS,
  title={Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).},
  author={Eun Joo Lee and Kyung Rae Kim and Sung Kil Lim and Hyun Chul Lee and Dong Il Kim and Su Hyun Kim and Kap Bum Huh},
  journal={European journal of endocrinology},
  year={1994},
  volume={131 1},
  pages={109-12}
}
We present a 55-year-old female with a thyrotropin (TSH)-secreting pituitary adenoma who had been treated with somatostatin analog octreotide acetate (SMS 201-995) for 4 months. Subcutaneous injection of 100 micrograms octreotide acetate twice daily resulted in significant reduction of the TSH, thyroid hormone, and tumor size. During the treatment, there was no evidence of any side effects. We may conclude that octreotide acetate administration is an effective treatment in patients with TSH… CONTINUE READING
3 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…